Adams Chetwood Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$951K Buy
8,575
+1,460
+21% +$154K 0.54% 36
2021
Q4
$736K Buy
7,115
+10
+0.1% +$1.16K 0.5% 41
2021
Q3
$891K Buy
7,105
+79
+1% +$10.2K 0.65% 35
2021
Q2
$872K Buy
7,026
+85
+1% +$10.7K 0.62% 36
2021
Q1
$820K Buy
6,941
+170
+3% +$19.9K 0.63% 34
2020
Q4
$793K Buy
6,771
+400
+6% +$44K 0.66% 34
2020
Q3
$662K Buy
6,371
+2,086
+49% +$209K 0.64% 36
2020
Q2
$393K Buy
4,285
+210
+5% +$20.1K 0.4% 50
2020
Q1
$404K Sell
4,075
-95
-2% -$10.1K 0.47% 46
2019
Q4
$473K Buy
+4,170
New +$458K 0.48% 41

Other funds holding MDT

Adams Chetwood Wealth Management's MDT Position: Q1 2022 in Review

Adams Chetwood Wealth Management increased its Medtronic (MDT) stake by 21% in Q1 2022, buying an estimated $154K and bringing the position to 8,575 shares worth $951K. The position accounts for 0.54% of the portfolio, ranked #36.

Adams Chetwood Wealth Management first reported a position in MDT in Q4 2019 and has held it in 10 quarters since. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Adams Chetwood Wealth Management held 8,575 shares of Medtronic worth $951K as of Q1 2022.
  • Adams Chetwood Wealth Management bought 1,460 Medtronic shares in Q1 2022, an estimated $154K.
  • Medtronic made up 0.54% of Adams Chetwood Wealth Management's portfolio in Q1 2022, its #36 holding.
  • Adams Chetwood Wealth Management first reported a position in Medtronic in Q4 2019 and has held it in 10 quarters since.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Adams Chetwood Wealth Management's 13F filing for Q1 2022, filed 13 Apr 2022.